Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...

Chikungunya cases have spiked substantially in La Réunion since early 2025, with 8,600 cases recorded and almost 3,000 new cases during the week of March 3 to 9, 2025 1. Similar to the 2005-2006 ...

VALNEVA Declaration of shares and voting rights ... 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: March 5, 2025 Number ...

SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...

Valneva also has an ongoing license agreement with the Serum Institute of India (SII) to supply its vaccine at an affordable ...

Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...

Yes, Valneva had another successful year in 2024 ... 2024 in the United States and at the end of the year in Canada and France and we recognized initial sales for the financial year 2024 of ...

Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is ...

Zeit Aktuelle Nachrichten 18:06 Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program Saint-Herblain (France), March 26, 2025 - Valneva SE (Nasdaq: VALN ...